These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21856599)

  • 21. Comparison of bioelectrical impedance with skinfold thickness and X-ray absorptiometry to measure body composition in HIV-infected with lipodistrophy.
    Siqueira Vassimon H; Jordao AA; Albuquerque de Paula FJ; Artioli Machado A; Pontes Monteiro J
    Nutr Hosp; 2011; 26(3):458-64. PubMed ID: 21892561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.
    Meininger G; Hadigan C; Laposata M; Brown J; Rabe J; Louca J; Aliabadi N; Grinspoon S
    Metabolism; 2002 Feb; 51(2):260-6. PubMed ID: 11833059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
    Huang JS; Rietschel P; Hadigan CM; Rosenthal DI; Grinspoon S
    AIDS; 2001 May; 15(8):975-82. PubMed ID: 11399979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of dual-energy X-ray absorptiometry machines for measuring fat distribution changes of HIV-associated lipodystrophy.
    Yang Y; Zhu WD; Paton NI
    Antivir Ther; 2004 Oct; 9(5):771-8. PubMed ID: 15535415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy.
    Bonnet E; Delpierre C; Sommet A; Marion-Latard F; Hervé R; Aquilina C; Labau E; Obadia M; Marchou B; Massip P; Perret B; Bernard J
    J Clin Densitom; 2005; 8(3):287-92. PubMed ID: 16055958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome.
    Iacobellis G; Sharma AM; Pellicelli AM; Grisorio B; Barbarini G; Barbaro G
    Curr HIV Res; 2007 Mar; 5(2):275-9. PubMed ID: 17346142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    AIDS; 2002 Nov; 16(16):2183-93. PubMed ID: 12409740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discordance between body mass index and anthropometric measurements among HIV-1-infected patients on antiretroviral therapy and with lipoatrophy/lipohypertrophy syndrome.
    Soares LR; da Silva DC; Gonsalez CR; Batista FG; Fonseca LA; Duarte AJ; Casseb J
    Rev Inst Med Trop Sao Paulo; 2015; 57(2):105-10. PubMed ID: 25923888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal study of body composition of 101 HIV men with lipodystrophy: dual-energy X-ray criteria for lipodystrophy evolution.
    Degris E; Delpierre C; Sommet A; Sire S; Lassoued S; Aquilina C; Marchou B; Massip P; Obadia M; Marion-Latard F; Bonnet E; Bernard J
    J Clin Densitom; 2010; 13(2):237-44. PubMed ID: 20347366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy.
    Brambilla P; Bricalli D; Sala N; Renzetti F; Manzoni P; Vanzulli A; Chiumello G; di Natale B; Viganò A
    AIDS; 2001 Dec; 15(18):2415-22. PubMed ID: 11740192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonography and anthropometry for measuring regional body fat in HIV-infected patients.
    Padilla S; Gallego JA; Masiá M; Ardoy F; Hernández I; Gutiérrez F
    Curr HIV Res; 2007 Sep; 5(5):459-66. PubMed ID: 17896965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial markers and HIV infection in the era of highly active antiretroviral treatment.
    de Larrañaga GF; Bocassi AR; Puga LM; Alonso BS; Benetucci JA
    Thromb Res; 2003 May; 110(2-3):93-8. PubMed ID: 12893023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.
    Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA
    HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition.
    Carter VM; Hoy JF; Bailey M; Colman PG; Nyulasi I; Mijch AM
    HIV Med; 2001 Jul; 2(3):174-80. PubMed ID: 11737398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carotid intima media thickness is associated with body fat abnormalities in HIV-infected patients.
    Freitas P; Carvalho D; Santos AC; Madureira AJ; Martinez E; Pereira J; Sarmento A; Medina JL
    BMC Infect Dis; 2014 Jun; 14():348. PubMed ID: 24958511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body composition and lipodystrophy in prepubertal HIV-infected children.
    Palchetti CZ; Patin RV; Gouvêa Ade F; Szejnfeld VL; Succi RC; Oliveira FL
    Braz J Infect Dis; 2013; 17(1):1-6. PubMed ID: 23318286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.
    McDermott AY; Shevitz A; Knox T; Roubenoff R; Kehayias J; Gorbach S
    Am J Clin Nutr; 2001 Nov; 74(5):679-86. PubMed ID: 11684538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.
    Hadigan C; Corcoran C; Piecuch S; Rodriguez W; Grinspoon S
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3544-50. PubMed ID: 11061499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.